CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Recordati Industria Chmc Frmctc SpA is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Recordati Industria Chmc Frmctc SpA
Via Matteo Civitali, 1
Phone: +39 02487871p:+39 02487871 MILANO, 20148  Italy Ticker: RECREC
Business Summary
Recordati Industria Chimica e Farmaceutica SpA is an Italy-based group engaged in the research, development, manufacture and marketing of pharmaceuticals. It promotes a wide range of pharmaceuticals, both proprietary and under license, in a number of therapeutic areas, such as Antibiotics and Antiviral, Cardiovascular, Central nervous system, Dermatological, Gastroenterology, Genital-urinary system, Muscular-skeletal disorders and pain therapy, Obstetrics and Gynecology and over the counter (OTC) pharmaceuticals. The Company is engaged in the research and development of new drug entities within the cardiovascular and urogenital therapeutic areas and of treatments for rare diseases. It’s product is ZANIDIP, a latest generation calcium-channel blocker for the treatment hypertension. It operates through Italchimici SpA, Pro Farma AG and North American marketing rights to Cystadane. The Company owns and operates through Natural Point srl also in the food supplement sector.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202312/31/2023Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
2833 Medicinal chemicals and botanical products
8731 Commercial physical and biological research
2099 Food preparations, not elsewhere classified

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Non-Executive Chairman of the Board AndreaRecordati 52 12/1/2021 3/1/2002
Chief Executive Officer, Executive Director RobertKoremans 61 12/1/2021 12/1/2021
Non-Executive Vice Chairman of the Board GuidoGuidi 70 4/29/2020 4/29/2020
12 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Italchimici S.p.A. Via Pontina Vecchia 29 Citta Metropolitana di Roma Italy
EUSA Pharma (UK) Ltd. Ground Floor, Suite F, Breakspear Park Hemel Hempstead United Kingdom
Recordati Rare Diseases Canada, Inc. 33 Bay Street Toronto ON Canada
Laboratorios Casen Fleet S.L.U. Carretera Logrono, Km 13,300 Utebo Zaragoza Spain

Business Names
Business Name
ArtMed International
Betadorm D
Bonafarma S.A.
56 additional Business Names available in full report.

General Information
Number of Employees: 4,455 (As of 12/31/2023)
Outstanding Shares: 206,006,112 (As of 12/31/2023)
Shareholders: 26,214
Stock Exchange: BIT
Fax Number: +39 0240073747


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Thursday, April 18, 2024